Hi Eire , I agree and have said as much before .
Have been concerned about funds and expenditure ( aware of the cost cuttings ) because these guys have had several CR to RAISE funds which have left loyal shareholders in the red .
It would be a no brainer for the company , if needed , to have their CR after further postive hsv-2 results . The scary scenario is a CR without the said Ann , you could then conclude that we are further away in progress than we would like to be .
In regards to the hpv I don't know how interconnected research is with the hsv-2 vaccine , it is still only in the phase 1 stage as opposed to phase 2 for the hsv-2 , we have been lucky enough to have received r and d grants , MAYBE that is the reason we can do the r and d on the hpv . Has the company ever revealed costs for the r and d of the hpv and the hsv -2 ? If grants are FULLY funding the HPv study then I have no issues with it proceeding , not that that counts for anything !
Still don't see how people can think we can fast track the hsv-2 , don't think some people realise what is involved in bringing this from : A to Z , happy to hear how we can " short cut " this process !
Hope next CR does make the change that will turn this company around , as I have a strong aversion now whenever Ahz and a CR are in the same sentence . If Prof Fraser hadn't been who he is ( AND his team ) / and the CardioCel progress I would have dumped this stock ages ago .
Be very careful Eire ..... no matter how strongly you believe in the story the shit can hit the fan , I have done the same as you have too ! Except I was silly enough to bloody average up and then no funds to catch this falling knife on the way down . I shall be a lot more pragmatic like some of the wiser posters who are trading , Russ etc .
This " love affair " with Ahz has certainly cooled off over the years .... perhaps it needs that spark to relight again !
The New Admedus, page-60
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$12.19 |
Change
-0.010(0.08%) |
Mkt cap ! $257.6M |
Open | High | Low | Value | Volume |
$12.19 | $12.19 | $12.19 | $207 | 17 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 777 | $11.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.19 | 2366 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 777 | 11.810 |
4 | 1274 | 11.800 |
1 | 80 | 11.750 |
2 | 772 | 11.600 |
2 | 2000 | 11.500 |
Price($) | Vol. | No. |
---|---|---|
12.190 | 2366 | 3 |
12.200 | 1981 | 2 |
12.480 | 446 | 1 |
12.500 | 500 | 1 |
12.850 | 99 | 1 |
Last trade - 10.25am 01/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
TON
TRITON MINERALS LTD
Adrian Costello, Executive Director
Adrian Costello
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online